Answer:
population I stars.
Explanation:
A star is a giant astronomical or celestial object that is comprised of a luminous sphere of plasma, binded together by its own gravitational force.
It is typically made up of two (2) main hot gas, Hydrogen (H) and Helium (He).
The luminosity of a star can be defined as the total amount of light radiated by the star per second and it is measured in watts (w). Also, the apparent brightness of a star is a measure of the rate at which radiated energy from a star reaches an observer on Earth per square meter per second. The apparent brightness of a star is typically measured in watts per square meter.
Some of the examples of stars are; Canopus, Sun (closest to the Earth), Betelgeus, Antares, Vega etc.
New stars that are found in the spiral arms and formed from recycled dead star material are known as population I stars. Also, it comprises of association and clusters formed a million or billion years ago in the spiral arms of Milky Way galaxy.
A galaxy can be defined as a collection or group of many billions of stars and other planetary body which are existing independently.
Answer:
Nonrenewable energy resources, like coal, nuclear, oil, and natural gas, are available in limited supplies. This is usually due to the long time it takes for them to be replenished. Renewable resources are replenished naturally and over relatively short periods of time.
Yes, it is true that Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis.
Enhancer of zeste homolog 2 (EZH2), a key histone methyltransferase and EMT inducer, is overexpressed in diverse carcinomas, including breast cancer.
However, the molecular mechanisms of EZH2 dysregulation in cancers are still largely unknown. Here, we discover that EZH2 is asymmetrically dimethylated at R342 (meR342-EZH2) by PRMT1.
meR342-EZH2 was found to inhibit the CDK1-mediated phosphorylation of EZH2 at T345 and T487, thereby attenuating EZH2 ubiquitylation mediated by the E3 ligase TRAF6.
We also demonstrate that meR342-EZH2 resulted in a decrease in EZH2 target gene expression, but an increase in breast cancer cell EMT, invasion and metastasis.
Moreover, we confirm the positive correlations among PRMT1, meR342-EZH2 and EZH2 expression in the breast cancer tissues. Finally, we report that high expression levels of meR342-EZH2 predict a poor clinical outcome in breast cancer patients.
Our findings may provide a novel diagnostic target and promising therapeutic target for breast cancer metastasis.
Learn more about breast cancer here : brainly.com/question/6747562
#SPJ4
Synergistic Interaction
Hope helps uh :)
